1-2 of 2
Feng Zhou
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 study of add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: final results

Clinical Trials & Observations
Abdulraheem Yacoub, Uma Borate, Raajit K. Rampal, Haris Ali, Eunice S. Wang, Aaron T. Gerds, Gabriela Hobbs, Marina Kremyanskaya, Elliott Winton, Casey O’Connell, Swati Goel, Stephen T. Oh, Gary Schiller, James McCloskey, Jeanne Palmer, Houston Holmes, Steven Hager, Albert Assad, Susan Erickson-Viitanen, Feng Zhou, Naval Daver
Journal: Blood Advances
Blood Adv (2024) 8 (6): 1515–1528.
https://doi.org/10.1182/bloodadvances.2023011620
Published: 2024
Includes: Supplemental data
Journal Articles

Aberrant expression of GOLM1 protects ALK + anaplastic large cell lymphoma from apoptosis by enhancing BCL-X L stability

Zhenguo Zi, Shujuan Du, Liming Zhang, Yuebo Wang, Ling Ding, Chongqi Zhang, Huanyu Wang, Jan Pawlicki, Yuan Cai, Yazhou Yao, Feng Zhou, Yin Tong, James L. Riley, Qiliang Cai, Xiaojing Ma, Fang Wei
Journal: Blood Advances
Blood Adv (2023) 7 (15): 4049–4063.
https://doi.org/10.1182/bloodadvances.2022008384
Published: 2023
Includes: Supplemental data